Postmarketing Surveillance to Investigate the Safety and Efficacy Information of Alesion® Tablet

Clinical trial NCT02238223 · COMPLETED

Trial details

NCT number: NCT02238223
Sponsor: Boehringer Ingelheim
Status: COMPLETED
Study type: OBSERVATIONAL

Rhinitis, Allergic, Perennial

Start date: 2004-04-01
Primary completion: 2006-05-01
Enrollment: 2001

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.